Clinical trials: Acute STEMI

Myocardial Infarction

Safety and Efficacy Study of MGuard Stent After a Heart Attack

• Completed
• Age: 18 years and older
• Phase 4
• Medical device

The goal of this study is to demonstrate the superiority of the MGuard™ stent over commercially-approved bare-metal (BMS) /drug-eluting stents (DES) in achieving better myocardial reperfusion in primary angioplasty for the…

Trial name

MASTER (NCT01368471)

Testing

MGuard, Control BMS or DES

Where

7 sites in Poland, South Africa

Volunteers

433 people, healthy volunteers welcome

Sponsor

InspireMD